Skip to main content
GNOM logo
GNOM
(NASDAQ)
Global X Genomics & Biotechnology ETF
$54.90-- (--)
Loading... - Market loading

GNOM ETF: Global X Genomics & Biotechnology ETF - Price, Holdings & Analysis

Global X Genomics & Biotechnology ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$54.52 - $55.14
52-Week High$59.48
52-Week Low$34.04
Open$54.52
Volume8.13K
Average Volume (3M)38.79K
Assets (AUM)59.59M
Expense Ratio0.50%
Total Holdings52
Inception DateApr 4, 2019
1 Day Change0.36%
1 Month Change2.08%
6 Month Change10.91%
YTD Change20.22%
1 Year Change52.16%
52-Week Change51.16%
5 Year Change-40.27%
50-Day MA$51.57
200-Day MA$46.97
RSI52.51
Stochastic %K29.32
Stochastic %D28.09
Annual Dividend$0.68
Dividend Yield1.24%
Last Dividend Ex-DateJul 7, 2026
Dividend Growth YoY1959.84%

Frequently Asked Questions About Global X Genomics & Biotechnology ETF

What is the current price of GNOM?

The latest GNOM price is $54.90. The 52-week range is $34.04–$59.48. GNOM has returned 51.2% over the past 52 weeks.

What is the expense ratio for GNOM?

GNOM's annual expense ratio is 0.50%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does GNOM pay dividends?

Yes, GNOM pays a 1.24% dividend yield. The last ex-dividend date was 2026-07-07. View full dividend history in the Dividends section.

What are the top holdings of GNOM?

GNOM's largest holdings are Guardant Health, Inc (5.7%), Twist Bioscience Corporation (5.0%), Illumina, Inc (5.0%) (combined weight: 15.7%). The fund holds 52 total positions. View the complete portfolio breakdown in the Holdings section.

How does GNOM compare to similar ETFs?

Compare GNOM (0.50% expense ratio, $60M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.